The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Transocean Ltd. — Neutral
RIG Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Transocean Ltd. ("Transocean" or "the Company") (NYSE:RIG) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Nextracker Inc. — Neutral
NXT Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nextracker Inc. ("Nextracker" or "the Company") (NASDAQ:NXT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 1, 2024 and August 1, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 25, 2025.
The Schall Law Firm Invites Investors With Losses In Liberty TripAdvisor Holdings, Inc. To Join A Securities Fraud Investigation — Neutral
LTRPA Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Liberty TripAdvisor Holdings, Inc. ("Liberty TripAdvisor" or "the Company") (OTCQB:LTRPA) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Liberty TripAdvisor board breached its fiduciary duties to shareholders.
Vacasa, Inc. Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm — Neutral
VCSA Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vacasa, Inc. ("Vacasa" or "the Company") (NASDAQ:VCSA) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vacasa board breached its fiduciary duties to shareholders.
AstraZeneca PLC Is Being Sued For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm — Neutral
AZN Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca" or "the Company") (NASDAQ:AZN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 23, 2022 and December 17, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 21, 2025.
The Schall Law Firm Invites Investors With Losses In Celanese Corporation To Join A Securities Fraud Investigation — Neutral
CE Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Celanese Corporation ("Celanese" or "the Company") (NYSE:CE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against Regeneron Pharmaceuticals, Inc. — Neutral
REGN Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 2, 2023 and October 30, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 10, 2025.
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc. — Neutral
APLT Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc. ("Applied Therapeutics" or "the Company") (NASDAQ:APLT) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 18, 2025.
DEADLINE APPROACHING: The Schall Law Firm Invites Shareholders With Losses To Reach Out About A Securities Fraud Case Against Enphase Energy, Inc. — Neutral
ENPH Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enphase Energy, Inc. ("Enphase" or "the Company") (NASDAQ:ENPH) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 25, 2023, and October 22, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 11, 2025.
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Micron Technology, Inc. — Neutral
MU Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Micron Technology, Inc. ("Micron" or "the Company") (NASDAQ:MU) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between September 28, 2023 and December 18, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 10, 2025.
The Schall Law Firm Invites Shareholders With Losses In XBiotech Inc. To Join A Securities Fraud Investigation — Neutral
XBIT Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of XBiotech Inc. ("XBiotech" or "the Company") (NASDAQ:XBIT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Innovative Industrial Properties, Inc. — Neutral
IIPR Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Innovative Industrial Properties, Inc. ("IIPR" or "the Company") (NYSE:IIPR) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 27, 2024 and December 19, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 18, 2025.
The Schall Law Firm Invites Investors With Losses In Carvana Co. To Join A Securities Fraud Investigation — Neutral
CVNA Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Carvana Co. ("Carvana" or "the Company") (NYSE:CVNA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Invites Shareholders With Losses In Dave Inc. To Join A Securities Fraud Investigation — Neutral
DAVE Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Dave Inc. ("Dave" or "the Company") (NASDAQ:DAVE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Case Against MGP Ingredients, Inc. — Neutral
MGPI Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MGP Ingredients, Inc. ("MGP Ingredients" or "the Company") (NASDAQ:MGPI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 4, 2023 to October 30, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 14, 2025.
The Schall Law Firm Invites Investors With Losses In TransMedics Group, Inc. To Join A Securities Fraud Investigation — Neutral
TMDX Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Southwest Airlines Co. Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
LUV Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Southwest Airlines Co. ("Southwest Airlines" or "the Company") (NYSE:LUV) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Invites Investors With Losses In e.l.f. Beauty, Inc. To Join A Securities Fraud Investigation — Neutral
ELF Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of e.l.f. Beauty, Inc. ("e.l.f.
Pactiv Evergreen Inc. Is Being Investigated For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm — Neutral
PTVE Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pactiv Evergreen Inc. ("Pactiv Evergreen" or "the Company") (NASDAQ:PTVE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Pactiv Evergreen board breached its fiduciary duties to shareholders.
The Schall Law Firm Invites Shareholders With Losses In Avid Bioservices, Inc. To Join A Securities Fraud Investigation — Neutral
CDMO Accesswire — February 10, 2025LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avid Bioservices, Inc. ("Avid" or "the Company") (NASDAQ:CDMO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Avid board breached its fiduciary duties to shareholders.
